10 Oct 2022 --- New cardiovascular research presented by the Odense University Hospital in Denmark at the European Society of Cardiology Congress has revealed a link between vitamin K2 MK-7 and D supplementation and coronary artery calcification (CAC) development – a strong predictor of acute myocardial infarction, also known as heart attack, and cardiovascular mortality. The double-blinded, placebo-controlled clinical trial was independently designed and performed by the research group. Kappa Bioscience’s vitamin K2 MK-7 solution (K2Vital Delta) was the active ingredient tested. The study concluded that the ingredient – together with vitamin D – might help to slow the progression of CAC.
